

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.47496530 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.47496530 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 5.47496530 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.47496530 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 5.47496530 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.47496530 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.30643278 |
| 8 | detection of other organism (GO:0098543) | 4.98829287 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.95936823 |
| 10 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.93340084 |
| 11 | retinal cone cell development (GO:0046549) | 4.76899893 |
| 12 | detection of bacterium (GO:0016045) | 4.75144070 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.71964662 |
| 14 | synaptic vesicle maturation (GO:0016188) | 4.58684149 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 4.58683017 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 4.58531097 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.46880344 |
| 18 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 4.31909354 |
| 19 | microglial cell activation (GO:0001774) | 4.31349058 |
| 20 | rhodopsin mediated signaling pathway (GO:0016056) | 4.24133758 |
| 21 | detection of external biotic stimulus (GO:0098581) | 4.23385697 |
| 22 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.21292053 |
| 23 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.21279752 |
| 24 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.20771464 |
| 25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.20033169 |
| 26 | detection of molecule of bacterial origin (GO:0032490) | 4.15415613 |
| 27 | locomotory exploration behavior (GO:0035641) | 4.09436234 |
| 28 | neutrophil activation (GO:0042119) | 4.05714845 |
| 29 | neutrophil mediated immunity (GO:0002446) | 4.02803352 |
| 30 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.98515519 |
| 31 | response to host immune response (GO:0052572) | 3.98161813 |
| 32 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.98161813 |
| 33 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.97696193 |
| 34 | response to interleukin-15 (GO:0070672) | 3.96889911 |
| 35 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.95958760 |
| 36 | respiratory burst (GO:0045730) | 3.95220486 |
| 37 | response to muramyl dipeptide (GO:0032495) | 3.85453288 |
| 38 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.79997973 |
| 39 | layer formation in cerebral cortex (GO:0021819) | 3.79838233 |
| 40 | negative regulation of cell killing (GO:0031342) | 3.75349189 |
| 41 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.75349189 |
| 42 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.73943533 |
| 43 | glomerular visceral epithelial cell development (GO:0072015) | 3.73775094 |
| 44 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.71483510 |
| 45 | detection of biotic stimulus (GO:0009595) | 3.70038132 |
| 46 | macrophage activation (GO:0042116) | 3.67102370 |
| 47 | cellular response to interleukin-15 (GO:0071350) | 3.66523624 |
| 48 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.65539085 |
| 49 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.64517509 |
| 50 | sodium ion export (GO:0071436) | 3.63573866 |
| 51 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.61149058 |
| 52 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.58318893 |
| 53 | response to host (GO:0075136) | 3.58318893 |
| 54 | response to host defenses (GO:0052200) | 3.58318893 |
| 55 | granulocyte activation (GO:0036230) | 3.57559757 |
| 56 | myeloid leukocyte mediated immunity (GO:0002444) | 3.51265364 |
| 57 | regulation of gamma-delta T cell activation (GO:0046643) | 3.50108424 |
| 58 | glomerular epithelial cell development (GO:0072310) | 3.48582663 |
| 59 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.48333142 |
| 60 | synaptic vesicle exocytosis (GO:0016079) | 3.47988975 |
| 61 | negative regulation of T cell mediated immunity (GO:0002710) | 3.47359698 |
| 62 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.47298909 |
| 63 | detection of light stimulus involved in visual perception (GO:0050908) | 3.47298909 |
| 64 | myeloid cell activation involved in immune response (GO:0002275) | 3.45922263 |
| 65 | regulation of mast cell degranulation (GO:0043304) | 3.45213213 |
| 66 | protein localization to synapse (GO:0035418) | 3.44375368 |
| 67 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.44299687 |
| 68 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.42160244 |
| 69 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.39150302 |
| 70 | cellular response to type I interferon (GO:0071357) | 3.38818048 |
| 71 | type I interferon signaling pathway (GO:0060337) | 3.38818048 |
| 72 | response to type I interferon (GO:0034340) | 3.36960756 |
| 73 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.32852368 |
| 74 | glutamate secretion (GO:0014047) | 3.31298906 |
| 75 | cellular potassium ion homeostasis (GO:0030007) | 3.29107831 |
| 76 | activated T cell proliferation (GO:0050798) | 3.23512530 |
| 77 | photoreceptor cell development (GO:0042461) | 3.20349215 |
| 78 | defense response to protozoan (GO:0042832) | 3.19911322 |
| 79 | regulation of leukocyte degranulation (GO:0043300) | 3.19898539 |
| 80 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.19675633 |
| 81 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.19443804 |
| 82 | positive regulation of mast cell activation (GO:0033005) | 3.19186628 |
| 83 | regulation of ARF protein signal transduction (GO:0032012) | 3.18494923 |
| 84 | leukocyte aggregation (GO:0070486) | 3.16830116 |
| 85 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.14849512 |
| 86 | leukocyte degranulation (GO:0043299) | 3.13544245 |
| 87 | photoreceptor cell maintenance (GO:0045494) | 3.12247712 |
| 88 | B cell receptor signaling pathway (GO:0050853) | 3.11025311 |
| 89 | eye photoreceptor cell development (GO:0042462) | 3.09179255 |
| 90 | vocalization behavior (GO:0071625) | 3.09015862 |
| 91 | regulation of mast cell activation (GO:0033003) | 3.07142288 |
| 92 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.01805141 |
| 93 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.01523962 |
| 94 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.99785469 |
| 95 | germinal center formation (GO:0002467) | 2.99107719 |
| 96 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.98409101 |
| 97 | immunoglobulin mediated immune response (GO:0016064) | 2.97460274 |
| 98 | adaptation of signaling pathway (GO:0023058) | 2.94414435 |
| 99 | exploration behavior (GO:0035640) | 2.93777258 |
| 100 | negative regulation of phagocytosis (GO:0050765) | 2.93278185 |
| 101 | negative regulation of interleukin-6 production (GO:0032715) | 2.90124504 |
| 102 | positive regulation of mast cell degranulation (GO:0043306) | 2.89913432 |
| 103 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.89913432 |
| 104 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.88932281 |
| 105 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.87667751 |
| 106 | phototransduction (GO:0007602) | 2.87475930 |
| 107 | regulation of synaptic vesicle transport (GO:1902803) | 2.87057777 |
| 108 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.86590876 |
| 109 | oxygen transport (GO:0015671) | 2.84771678 |
| 110 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.84347083 |
| 111 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.83265018 |
| 112 | response to pheromone (GO:0019236) | 2.82843039 |
| 113 | response to protozoan (GO:0001562) | 2.82778192 |
| 114 | defense response to fungus (GO:0050832) | 2.81863983 |
| 115 | detection of light stimulus (GO:0009583) | 2.78313978 |
| 116 | regulation of macrophage cytokine production (GO:0010935) | 2.76316613 |
| 117 | response to interferon-alpha (GO:0035455) | 2.76089648 |
| 118 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.75942299 |
| 119 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.75942299 |
| 120 | negative regulation of type 2 immune response (GO:0002829) | 2.74612022 |
| 121 | regulation of guanylate cyclase activity (GO:0031282) | 2.74354283 |
| 122 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.74263079 |
| 123 | negative regulation of B cell mediated immunity (GO:0002713) | 2.73636065 |
| 124 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.73636065 |
| 125 | retinal rod cell development (GO:0046548) | 2.73605136 |
| 126 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.72714735 |
| 127 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.72714735 |
| 128 | response to fungus (GO:0009620) | 2.72370475 |
| 129 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.71614141 |
| 130 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.71491456 |
| 131 | regulation of B cell differentiation (GO:0045577) | 2.71017325 |
| 132 | positive regulation of Rap GTPase activity (GO:0032854) | 2.70837454 |
| 133 | regulation of synapse structural plasticity (GO:0051823) | 2.70438592 |
| 134 | protein-chromophore linkage (GO:0018298) | 2.67421058 |
| 135 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.66849082 |
| 136 | regulation of tolerance induction (GO:0002643) | 2.66004784 |
| 137 | detection of visible light (GO:0009584) | 2.65417531 |
| 138 | dendritic spine morphogenesis (GO:0060997) | 2.64596350 |
| 139 | establishment of nucleus localization (GO:0040023) | 2.62304406 |
| 140 | positive regulation of synapse maturation (GO:0090129) | 2.61325290 |
| 141 | phototransduction, visible light (GO:0007603) | 2.60763053 |
| 142 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.55512590 |
| 143 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.54397971 |
| 144 | proline transport (GO:0015824) | 2.52707145 |
| 145 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.48877374 |
| 146 | cellular extravasation (GO:0045123) | 2.45338568 |
| 147 | synaptic vesicle endocytosis (GO:0048488) | 2.43789868 |
| 148 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.38970207 |
| 149 | cell communication by electrical coupling (GO:0010644) | 2.38708743 |
| 150 | negative regulation of interleukin-12 production (GO:0032695) | 2.38487393 |
| 151 | neurotransmitter secretion (GO:0007269) | 2.37384838 |
| 152 | dendrite morphogenesis (GO:0048813) | 2.35133365 |
| 153 | response to auditory stimulus (GO:0010996) | 2.34905843 |
| 154 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.33579784 |
| 155 | nucleobase catabolic process (GO:0046113) | 2.32987836 |
| 156 | positive regulation of axon extension (GO:0045773) | 2.32204167 |
| 157 | positive regulation of membrane potential (GO:0045838) | 2.31643893 |
| 158 | innervation (GO:0060384) | 2.31554854 |
| 159 | nerve growth factor signaling pathway (GO:0038180) | 2.29870924 |
| 160 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.29577927 |
| 161 | neutrophil chemotaxis (GO:0030593) | 2.28224929 |
| 162 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.27429615 |
| 163 | visual perception (GO:0007601) | 2.26847605 |
| 164 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.26020814 |
| 165 | glomerular basement membrane development (GO:0032836) | 2.24802028 |
| 166 | sensory perception of light stimulus (GO:0050953) | 2.24040235 |
| 167 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.23816482 |
| 168 | regulation of axon guidance (GO:1902667) | 2.23693666 |
| 169 | clathrin coat assembly (GO:0048268) | 2.23691329 |
| 170 | neuron recognition (GO:0008038) | 2.22269049 |
| 171 | response to peptidoglycan (GO:0032494) | 2.22209348 |
| 172 | neutrophil migration (GO:1990266) | 2.22085508 |
| 173 | axonal fasciculation (GO:0007413) | 2.21837032 |
| 174 | regulation of ARF GTPase activity (GO:0032312) | 2.21771887 |
| 175 | activation of protein kinase A activity (GO:0034199) | 2.21498460 |
| 176 | axon extension (GO:0048675) | 2.18449117 |
| 177 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.14115748 |
| 178 | mitochondrion transport along microtubule (GO:0047497) | 2.14115748 |
| 179 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.13645780 |
| 180 | granulocyte migration (GO:0097530) | 2.13225489 |
| 181 | regulation of regulated secretory pathway (GO:1903305) | 2.12952740 |
| 182 | potassium ion import (GO:0010107) | 2.12567670 |
| 183 | long-term memory (GO:0007616) | 2.11452865 |
| 184 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.11440021 |
| 185 | positive regulation of neurotransmitter transport (GO:0051590) | 2.10407698 |
| 186 | neuromuscular process controlling balance (GO:0050885) | 2.10276063 |
| 187 | synaptic transmission, glutamatergic (GO:0035249) | 2.09773430 |
| 188 | positive regulation of histone deacetylation (GO:0031065) | 2.09510941 |
| 189 | regulation of neurotransmitter secretion (GO:0046928) | 2.09420351 |
| 190 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.07532603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.32319564 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.87540812 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.52410563 |
| 4 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.38981138 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.33108332 |
| 6 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.30258949 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.22947910 |
| 8 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.19198455 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.18623890 |
| 10 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.13340623 |
| 11 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.10350303 |
| 12 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.07523745 |
| 13 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.00098382 |
| 14 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.96790062 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.96194165 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.93289620 |
| 17 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.90803299 |
| 18 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.90580757 |
| 19 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.87740092 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.86473829 |
| 21 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.85934897 |
| 22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.85901193 |
| 23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.85901193 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.85275866 |
| 25 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.84151712 |
| 26 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.81759035 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 1.77235249 |
| 28 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.75492001 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.73613044 |
| 30 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.73598021 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73513828 |
| 32 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.72977380 |
| 33 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.72035714 |
| 34 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.69936976 |
| 35 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.69007540 |
| 36 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.67514276 |
| 37 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63122286 |
| 38 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.60977724 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60744597 |
| 40 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.60142447 |
| 41 | MYB_26560356_Chip-Seq_TH2_Human | 1.58242219 |
| 42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.58169674 |
| 43 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.53609858 |
| 44 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.53566120 |
| 45 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.49857404 |
| 46 | MAF_26560356_Chip-Seq_TH2_Human | 1.48394117 |
| 47 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.46917386 |
| 48 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.46810408 |
| 49 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.46035437 |
| 50 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.42028420 |
| 51 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.41436866 |
| 52 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39822727 |
| 53 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.38239790 |
| 54 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.37910118 |
| 55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.35922741 |
| 56 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.35144041 |
| 57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.34465281 |
| 58 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.32979508 |
| 59 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32686380 |
| 60 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.32179967 |
| 61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.31254950 |
| 62 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.30728601 |
| 63 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.30548148 |
| 64 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.29222132 |
| 65 | MYB_26560356_Chip-Seq_TH1_Human | 1.29021834 |
| 66 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.27169153 |
| 67 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.27036493 |
| 68 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.26552333 |
| 69 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.26355701 |
| 70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26261076 |
| 71 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25305114 |
| 72 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.24804290 |
| 73 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.22770615 |
| 74 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20829519 |
| 75 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.19317038 |
| 76 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.16980602 |
| 77 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.16844916 |
| 78 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.15882279 |
| 79 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.12995827 |
| 80 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12489057 |
| 81 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12388202 |
| 82 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.11801184 |
| 83 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.11418339 |
| 84 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11237822 |
| 85 | MYC_22102868_ChIP-Seq_BL_Human | 1.09990302 |
| 86 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.09970447 |
| 87 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.08936856 |
| 88 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.08304162 |
| 89 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.08206037 |
| 90 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.07260946 |
| 91 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06193831 |
| 92 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06161809 |
| 93 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.05098691 |
| 94 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04795014 |
| 95 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.04604538 |
| 96 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.04551831 |
| 97 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.04459007 |
| 98 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.04247522 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04163692 |
| 100 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04016377 |
| 101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03538868 |
| 102 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03188769 |
| 103 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.02962780 |
| 104 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02957112 |
| 105 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.02518840 |
| 106 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.02014237 |
| 107 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00456431 |
| 108 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.00010432 |
| 109 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.99796515 |
| 110 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.99124846 |
| 111 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.98085015 |
| 112 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.97902363 |
| 113 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.97880454 |
| 114 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.97435039 |
| 115 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97256313 |
| 116 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.96993502 |
| 117 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.96465099 |
| 118 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95798326 |
| 119 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.95603828 |
| 120 | P68_20966046_ChIP-Seq_HELA_Human | 0.95553945 |
| 121 | * AR_19668381_ChIP-Seq_PC3_Human | 0.95358598 |
| 122 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.94666483 |
| 123 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94253964 |
| 124 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.93903431 |
| 125 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.92724916 |
| 126 | GATA1_22025678_ChIP-Seq_K562_Human | 0.92589880 |
| 127 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.92573952 |
| 128 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92003474 |
| 129 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.91651700 |
| 130 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91350841 |
| 131 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91276046 |
| 132 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91267770 |
| 133 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.91150530 |
| 134 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90043511 |
| 135 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89853014 |
| 136 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88693353 |
| 137 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87465807 |
| 138 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.87284372 |
| 139 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87188889 |
| 140 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87007145 |
| 141 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.86554453 |
| 142 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86523129 |
| 143 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.86378423 |
| 144 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86290172 |
| 145 | MAF_26560356_Chip-Seq_TH1_Human | 0.85989076 |
| 146 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.85237340 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.00224647 |
| 2 | MP0005551_abnormal_eye_electrophysiolog | 4.25654079 |
| 3 | MP0003303_peritoneal_inflammation | 3.65221325 |
| 4 | MP0003011_delayed_dark_adaptation | 3.42731928 |
| 5 | MP0005253_abnormal_eye_physiology | 2.91759553 |
| 6 | MP0006072_abnormal_retinal_apoptosis | 2.89838843 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 2.54223274 |
| 8 | MP0004510_myositis | 2.46171920 |
| 9 | MP0005423_abnormal_somatic_nervous | 2.39731017 |
| 10 | MP0004270_analgesia | 2.25843266 |
| 11 | MP0006082_CNS_inflammation | 2.17230696 |
| 12 | MP0004858_abnormal_nervous_system | 2.15412220 |
| 13 | MP0000569_abnormal_digit_pigmentation | 2.12653498 |
| 14 | MP0002063_abnormal_learning/memory/cond | 2.08517305 |
| 15 | MP0002090_abnormal_vision | 1.96766615 |
| 16 | MP0002735_abnormal_chemical_nociception | 1.94480498 |
| 17 | MP0008260_abnormal_autophagy | 1.92043777 |
| 18 | MP0003436_decreased_susceptibility_to | 1.91742537 |
| 19 | MP0003690_abnormal_glial_cell | 1.91178666 |
| 20 | MP0008961_abnormal_basal_metabolism | 1.85343726 |
| 21 | MP0005195_abnormal_posterior_eye | 1.84367620 |
| 22 | MP0002396_abnormal_hematopoietic_system | 1.83963734 |
| 23 | MP0009278_abnormal_bone_marrow | 1.79511220 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.79060020 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.75115698 |
| 26 | MP0002132_abnormal_respiratory_system | 1.70664640 |
| 27 | MP0003183_abnormal_peptide_metabolism | 1.67072419 |
| 28 | MP0003075_altered_response_to | 1.65643023 |
| 29 | MP0002398_abnormal_bone_marrow | 1.65356798 |
| 30 | MP0005076_abnormal_cell_differentiation | 1.63487889 |
| 31 | MP0000716_abnormal_immune_system | 1.62578070 |
| 32 | MP0003172_abnormal_lysosome_physiology | 1.62457705 |
| 33 | MP0001348_abnormal_lacrimal_gland | 1.60744979 |
| 34 | MP0002277_abnormal_respiratory_mucosa | 1.59849814 |
| 35 | MP0002064_seizures | 1.59795513 |
| 36 | MP0003763_abnormal_thymus_physiology | 1.59736225 |
| 37 | MP0001968_abnormal_touch/_nociception | 1.59087088 |
| 38 | MP0009745_abnormal_behavioral_response | 1.57457796 |
| 39 | MP0003866_abnormal_defecation | 1.54112097 |
| 40 | MP0003828_pulmonary_edema | 1.51607364 |
| 41 | MP0003879_abnormal_hair_cell | 1.51096015 |
| 42 | MP0001986_abnormal_taste_sensitivity | 1.49684901 |
| 43 | MP0009764_decreased_sensitivity_to | 1.43350933 |
| 44 | MP0001790_abnormal_immune_system | 1.43246007 |
| 45 | MP0005387_immune_system_phenotype | 1.43246007 |
| 46 | MP0002734_abnormal_mechanical_nocicepti | 1.42375709 |
| 47 | * MP0001486_abnormal_startle_reflex | 1.41002958 |
| 48 | MP0001502_abnormal_circadian_rhythm | 1.39641754 |
| 49 | MP0002229_neurodegeneration | 1.39528726 |
| 50 | MP0009046_muscle_twitch | 1.38348663 |
| 51 | MP0004885_abnormal_endolymph | 1.37278526 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.36343407 |
| 53 | MP0003329_amyloid_beta_deposits | 1.35259430 |
| 54 | MP0009785_altered_susceptibility_to | 1.35126353 |
| 55 | MP0002419_abnormal_innate_immunity | 1.34405930 |
| 56 | MP0003787_abnormal_imprinting | 1.32297922 |
| 57 | MP0004811_abnormal_neuron_physiology | 1.30910280 |
| 58 | MP0002572_abnormal_emotion/affect_behav | 1.30585631 |
| 59 | MP0001501_abnormal_sleep_pattern | 1.30055171 |
| 60 | MP0002882_abnormal_neuron_morphology | 1.29988655 |
| 61 | MP0000778_abnormal_nervous_system | 1.29810776 |
| 62 | MP0008569_lethality_at_weaning | 1.28381059 |
| 63 | MP0001324_abnormal_eye_pigmentation | 1.27744931 |
| 64 | MP0003880_abnormal_central_pattern | 1.26247114 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 1.26097626 |
| 66 | MP0001545_abnormal_hematopoietic_system | 1.26097626 |
| 67 | MP0005000_abnormal_immune_tolerance | 1.24240048 |
| 68 | MP0010155_abnormal_intestine_physiology | 1.23943966 |
| 69 | MP0000685_abnormal_immune_system | 1.22412852 |
| 70 | MP0004947_skin_inflammation | 1.21486901 |
| 71 | MP0002736_abnormal_nociception_after | 1.21275023 |
| 72 | MP0002429_abnormal_blood_cell | 1.20534025 |
| 73 | MP0002722_abnormal_immune_system | 1.20133865 |
| 74 | MP0005391_vision/eye_phenotype | 1.18894822 |
| 75 | MP0001851_eye_inflammation | 1.17647283 |
| 76 | MP0000689_abnormal_spleen_morphology | 1.17491700 |
| 77 | MP0005310_abnormal_salivary_gland | 1.17227213 |
| 78 | MP0003300_gastrointestinal_ulcer | 1.15603305 |
| 79 | MP0001440_abnormal_grooming_behavior | 1.14406843 |
| 80 | MP0001533_abnormal_skeleton_physiology | 1.13342922 |
| 81 | MP0000703_abnormal_thymus_morphology | 1.13300180 |
| 82 | MP0002653_abnormal_ependyma_morphology | 1.12890745 |
| 83 | MP0001970_abnormal_pain_threshold | 1.12346453 |
| 84 | MP0004381_abnormal_hair_follicle | 1.11058290 |
| 85 | MP0002733_abnormal_thermal_nociception | 1.11023319 |
| 86 | MP0008469_abnormal_protein_level | 1.09178423 |
| 87 | MP0002909_abnormal_adrenal_gland | 1.07833375 |
| 88 | MP0004883_abnormal_blood_vessel | 1.07739641 |
| 89 | MP0001835_abnormal_antigen_presentation | 1.06800237 |
| 90 | MP0004130_abnormal_muscle_cell | 1.06705616 |
| 91 | MP0001800_abnormal_humoral_immune | 1.05505950 |
| 92 | MP0005025_abnormal_response_to | 1.05488702 |
| 93 | MP0003045_fibrosis | 1.04796418 |
| 94 | MP0002184_abnormal_innervation | 1.02095571 |
| 95 | MP0002452_abnormal_antigen_presenting | 1.01082543 |
| 96 | MP0002752_abnormal_somatic_nervous | 1.00572467 |
| 97 | MP0002928_abnormal_bile_duct | 1.00168887 |
| 98 | MP0000604_amyloidosis | 0.97359418 |
| 99 | MP0003634_abnormal_glial_cell | 0.96706990 |
| 100 | MP0005623_abnormal_meninges_morphology | 0.96506172 |
| 101 | MP0001819_abnormal_immune_cell | 0.96181199 |
| 102 | MP0002420_abnormal_adaptive_immunity | 0.95850542 |
| 103 | MP0002723_abnormal_immune_serum | 0.95773263 |
| 104 | MP0005671_abnormal_response_to | 0.95770960 |
| 105 | MP0002067_abnormal_sensory_capabilities | 0.95294494 |
| 106 | MP0000920_abnormal_myelination | 0.92371977 |
| 107 | MP0000015_abnormal_ear_pigmentation | 0.91270806 |
| 108 | MP0002148_abnormal_hypersensitivity_rea | 0.90762892 |
| 109 | MP0005390_skeleton_phenotype | 0.88658848 |
| 110 | MP0004233_abnormal_muscle_weight | 0.88596017 |
| 111 | MP0000955_abnormal_spinal_cord | 0.86363437 |
| 112 | MP0002272_abnormal_nervous_system | 0.85077967 |
| 113 | MP0005464_abnormal_platelet_physiology | 0.84673166 |
| 114 | MP0005166_decreased_susceptibility_to | 0.83061735 |
| 115 | MP0003091_abnormal_cell_migration | 0.82553128 |
| 116 | MP0004742_abnormal_vestibular_system | 0.81918906 |
| 117 | MP0005075_abnormal_melanosome_morpholog | 0.81545586 |
| 118 | MP0003633_abnormal_nervous_system | 0.80605281 |
| 119 | MP0005377_hearing/vestibular/ear_phenot | 0.79602918 |
| 120 | MP0003878_abnormal_ear_physiology | 0.79602918 |
| 121 | MP0002089_abnormal_postnatal_growth/wei | 0.78498676 |
| 122 | MP0005164_abnormal_response_to | 0.77367376 |
| 123 | MP0002405_respiratory_system_inflammati | 0.73720110 |
| 124 | MP0010352_gastrointestinal_tract_polyps | 0.73508203 |
| 125 | MP0009765_abnormal_xenobiotic_induced | 0.72016226 |
| 126 | MP0005167_abnormal_blood-brain_barrier | 0.72013231 |
| 127 | MP0001845_abnormal_inflammatory_respons | 0.71748255 |
| 128 | MP0004924_abnormal_behavior | 0.71098274 |
| 129 | MP0005386_behavior/neurological_phenoty | 0.71098274 |
| 130 | MP0005535_abnormal_body_temperature | 0.70537430 |
| 131 | MP0002066_abnormal_motor_capabilities/c | 0.70452903 |
| 132 | MP0001485_abnormal_pinna_reflex | 0.69662662 |
| 133 | MP0005083_abnormal_biliary_tract | 0.69385105 |
| 134 | MP0002998_abnormal_bone_remodeling | 0.67632210 |
| 135 | MP0002133_abnormal_respiratory_system | 0.67363538 |
| 136 | MP0002557_abnormal_social/conspecific_i | 0.65237836 |
| 137 | MP0002638_abnormal_pupillary_reflex | 0.64288143 |
| 138 | MP0005187_abnormal_penis_morphology | 0.63951815 |
| 139 | MP0008874_decreased_physiological_sensi | 0.63406858 |
| 140 | MP0003724_increased_susceptibility_to | 0.63269912 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 7.17569124 |
| 2 | Bony spicule pigmentary retinopathy (HP:0007737) | 5.79151738 |
| 3 | Central scotoma (HP:0000603) | 5.70885563 |
| 4 | Hypochromic microcytic anemia (HP:0004840) | 5.66063994 |
| 5 | Dyschromatopsia (HP:0007641) | 5.42508506 |
| 6 | Abnormality of macular pigmentation (HP:0008002) | 4.74612719 |
| 7 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 4.70512576 |
| 8 | Pigmentary retinal degeneration (HP:0001146) | 4.62626013 |
| 9 | Abnormal rod and cone electroretinograms (HP:0008323) | 4.55766184 |
| 10 | Scotoma (HP:0000575) | 4.44288195 |
| 11 | Gastrointestinal infarctions (HP:0005244) | 3.98590955 |
| 12 | Hypochromic anemia (HP:0001931) | 3.97432258 |
| 13 | Recurrent skin infections (HP:0001581) | 3.94693681 |
| 14 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.91910081 |
| 15 | Recurrent cutaneous fungal infections (HP:0011370) | 3.91910081 |
| 16 | Meningitis (HP:0001287) | 3.86257944 |
| 17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.61857388 |
| 18 | Keratoconjunctivitis sicca (HP:0001097) | 3.59599967 |
| 19 | Pendular nystagmus (HP:0012043) | 3.55612672 |
| 20 | Episodic fever (HP:0001954) | 3.46007722 |
| 21 | Chorioretinal atrophy (HP:0000533) | 3.43544181 |
| 22 | Increased IgE level (HP:0003212) | 3.38145332 |
| 23 | Encephalitis (HP:0002383) | 3.34657943 |
| 24 | Keratoconjunctivitis (HP:0001096) | 3.34014091 |
| 25 | Eczematoid dermatitis (HP:0000976) | 3.32085757 |
| 26 | Prolonged bleeding time (HP:0003010) | 3.29584939 |
| 27 | Abolished electroretinogram (ERG) (HP:0000550) | 3.22349655 |
| 28 | Spontaneous hematomas (HP:0007420) | 3.18521637 |
| 29 | Peritonitis (HP:0002586) | 3.15752760 |
| 30 | Posterior subcapsular cataract (HP:0007787) | 3.14897561 |
| 31 | Photophobia (HP:0000613) | 3.14461222 |
| 32 | Hemoptysis (HP:0002105) | 3.14322322 |
| 33 | Supranuclear gaze palsy (HP:0000605) | 3.13694928 |
| 34 | Urticaria (HP:0001025) | 3.12526422 |
| 35 | Attenuation of retinal blood vessels (HP:0007843) | 3.07378106 |
| 36 | Decreased central vision (HP:0007663) | 3.06319904 |
| 37 | Recurrent abscess formation (HP:0002722) | 3.05899822 |
| 38 | Choroideremia (HP:0001139) | 3.03150229 |
| 39 | Chest pain (HP:0100749) | 3.00030819 |
| 40 | Myokymia (HP:0002411) | 2.97613327 |
| 41 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.97166891 |
| 42 | Macular degeneration (HP:0000608) | 2.91705587 |
| 43 | Interstitial pulmonary disease (HP:0006530) | 2.87108131 |
| 44 | Type II diabetes mellitus (HP:0005978) | 2.82948530 |
| 45 | Visual hallucinations (HP:0002367) | 2.75754609 |
| 46 | Microcytic anemia (HP:0001935) | 2.75687119 |
| 47 | Mutism (HP:0002300) | 2.64569308 |
| 48 | Recurrent bacterial skin infections (HP:0005406) | 2.62731648 |
| 49 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.61449700 |
| 50 | Severe visual impairment (HP:0001141) | 2.60028022 |
| 51 | Constricted visual fields (HP:0001133) | 2.59599662 |
| 52 | Leukocytosis (HP:0001974) | 2.59370100 |
| 53 | Epileptic encephalopathy (HP:0200134) | 2.55854475 |
| 54 | Amyloidosis (HP:0011034) | 2.55255022 |
| 55 | Retrobulbar optic neuritis (HP:0100654) | 2.54861610 |
| 56 | Optic neuritis (HP:0100653) | 2.54861610 |
| 57 | Pulmonary embolism (HP:0002204) | 2.54842704 |
| 58 | Increased corneal curvature (HP:0100692) | 2.45097039 |
| 59 | Keratoconus (HP:0000563) | 2.45097039 |
| 60 | Cone-rod dystrophy (HP:0000548) | 2.43704086 |
| 61 | Anorexia (HP:0002039) | 2.41937761 |
| 62 | Focal seizures (HP:0007359) | 2.38557529 |
| 63 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.38368331 |
| 64 | Mediastinal lymphadenopathy (HP:0100721) | 2.37430362 |
| 65 | Epistaxis (HP:0000421) | 2.36462772 |
| 66 | Gingival bleeding (HP:0000225) | 2.35856068 |
| 67 | Progressive visual loss (HP:0000529) | 2.33986277 |
| 68 | Orchitis (HP:0100796) | 2.33695000 |
| 69 | Papilledema (HP:0001085) | 2.32881251 |
| 70 | Sepsis (HP:0100806) | 2.32688776 |
| 71 | Abnormality of the endocardium (HP:0004306) | 2.32161679 |
| 72 | Focal motor seizures (HP:0011153) | 2.30613864 |
| 73 | Stomatitis (HP:0010280) | 2.30106879 |
| 74 | Slow saccadic eye movements (HP:0000514) | 2.25577616 |
| 75 | Panhypogammaglobulinemia (HP:0003139) | 2.25108769 |
| 76 | Myositis (HP:0100614) | 2.24888095 |
| 77 | Autoimmune thrombocytopenia (HP:0001973) | 2.24772002 |
| 78 | Abnormality of the pleura (HP:0002103) | 2.22008192 |
| 79 | Vertigo (HP:0002321) | 2.21950854 |
| 80 | Vitreoretinal degeneration (HP:0000655) | 2.21647479 |
| 81 | Osteomyelitis (HP:0002754) | 2.17663162 |
| 82 | Cheilitis (HP:0100825) | 2.17519044 |
| 83 | Febrile seizures (HP:0002373) | 2.13137054 |
| 84 | Genetic anticipation (HP:0003743) | 2.12982205 |
| 85 | Abnormality of the peritoneum (HP:0002585) | 2.12159739 |
| 86 | Granulocytopenia (HP:0001913) | 2.12025704 |
| 87 | Subcapsular cataract (HP:0000523) | 2.10286042 |
| 88 | Petechiae (HP:0000967) | 2.07555547 |
| 89 | Inflammation of the large intestine (HP:0002037) | 2.07058979 |
| 90 | Abnormality of macrophages (HP:0004311) | 2.06253585 |
| 91 | Difficulty running (HP:0009046) | 2.05896935 |
| 92 | Toxemia of pregnancy (HP:0100603) | 2.04787368 |
| 93 | Recurrent viral infections (HP:0004429) | 2.04408486 |
| 94 | Aqueductal stenosis (HP:0002410) | 2.04110710 |
| 95 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.03051901 |
| 96 | Abnormal hemoglobin (HP:0011902) | 2.02467502 |
| 97 | Ankle clonus (HP:0011448) | 2.00961041 |
| 98 | Progressive cerebellar ataxia (HP:0002073) | 2.00821636 |
| 99 | Acne (HP:0001061) | 1.99581866 |
| 100 | Gastrointestinal inflammation (HP:0004386) | 1.98781038 |
| 101 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.98241004 |
| 102 | Abnormality of the pericardium (HP:0001697) | 1.97031494 |
| 103 | Gangrene (HP:0100758) | 1.94539926 |
| 104 | Gingivitis (HP:0000230) | 1.93800729 |
| 105 | Action tremor (HP:0002345) | 1.91584117 |
| 106 | Polycythemia (HP:0001901) | 1.91299044 |
| 107 | Diplopia (HP:0000651) | 1.91216120 |
| 108 | Abnormality of binocular vision (HP:0011514) | 1.91216120 |
| 109 | Chronic otitis media (HP:0000389) | 1.90399272 |
| 110 | Obstructive lung disease (HP:0006536) | 1.89946126 |
| 111 | Chronic obstructive pulmonary disease (HP:0006510) | 1.89946126 |
| 112 | Hyperacusis (HP:0010780) | 1.89656539 |
| 113 | Inappropriate behavior (HP:0000719) | 1.87411243 |
| 114 | Hypergammaglobulinemia (HP:0010702) | 1.86911045 |
| 115 | Neuronal loss in central nervous system (HP:0002529) | 1.84539469 |
| 116 | Macroorchidism (HP:0000053) | 1.84506219 |
| 117 | Increased IgM level (HP:0003496) | 1.84427219 |
| 118 | Recurrent fungal infections (HP:0002841) | 1.84105967 |
| 119 | Apathy (HP:0000741) | 1.83355134 |
| 120 | Cellulitis (HP:0100658) | 1.82443611 |
| 121 | T lymphocytopenia (HP:0005403) | 1.82068401 |
| 122 | Truncal ataxia (HP:0002078) | 1.81945813 |
| 123 | Poor eye contact (HP:0000817) | 1.81431993 |
| 124 | Metaphyseal cupping (HP:0003021) | 1.80836527 |
| 125 | Glomerulopathy (HP:0100820) | 1.80677171 |
| 126 | Impaired social interactions (HP:0000735) | 1.80138912 |
| 127 | Abnormal social behavior (HP:0012433) | 1.80138912 |
| 128 | Abnormality of T cell number (HP:0011839) | 1.79538566 |
| 129 | Anomalous pulmonary venous return (HP:0010772) | 1.79309169 |
| 130 | Abnormality of T cells (HP:0002843) | 1.78899750 |
| 131 | Rapidly progressive (HP:0003678) | 1.78863444 |
| 132 | Obstructive sleep apnea (HP:0002870) | 1.77434822 |
| 133 | Depression (HP:0000716) | 1.76858895 |
| 134 | Hemiplegia (HP:0002301) | 1.76805152 |
| 135 | Absence seizures (HP:0002121) | 1.76119555 |
| 136 | Annular pancreas (HP:0001734) | 1.75811601 |
| 137 | Skin rash (HP:0000988) | 1.75606133 |
| 138 | Pustule (HP:0200039) | 1.75588933 |
| 139 | Nasal polyposis (HP:0100582) | 1.74703136 |
| 140 | Postural instability (HP:0002172) | 1.73606139 |
| 141 | Skin ulcer (HP:0200042) | 1.72967773 |
| 142 | Eosinophilia (HP:0001880) | 1.71957486 |
| 143 | Neurofibrillary tangles (HP:0002185) | 1.71742709 |
| 144 | Mesangial abnormality (HP:0001966) | 1.71369178 |
| 145 | Retinitis pigmentosa (HP:0000510) | 1.70876891 |
| 146 | Hematochezia (HP:0002573) | 1.70471126 |
| 147 | Hypermelanotic macule (HP:0001034) | 1.68834895 |
| 148 | Nephritis (HP:0000123) | 1.68434651 |
| 149 | Generalized tonic-clonic seizures (HP:0002069) | 1.67155001 |
| 150 | Arterial thrombosis (HP:0004420) | 1.65292614 |
| 151 | Retinal atrophy (HP:0001105) | 1.65086406 |
| 152 | Diminished motivation (HP:0000745) | 1.65018502 |
| 153 | Dysdiadochokinesis (HP:0002075) | 1.64706334 |
| 154 | Abnormality of the lower motor neuron (HP:0002366) | 1.62640353 |
| 155 | Urinary urgency (HP:0000012) | 1.61944777 |
| 156 | Insomnia (HP:0100785) | 1.60904543 |
| 157 | Amyotrophic lateral sclerosis (HP:0007354) | 1.60319329 |
| 158 | Vasculitis (HP:0002633) | 1.60216012 |
| 159 | Cerebral inclusion bodies (HP:0100314) | 1.59315922 |
| 160 | Glomerulonephritis (HP:0000099) | 1.58472114 |
| 161 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.58284471 |
| 162 | Enlarged penis (HP:0000040) | 1.56962871 |
| 163 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.56719307 |
| 164 | Stereotypic behavior (HP:0000733) | 1.56600186 |
| 165 | Broad-based gait (HP:0002136) | 1.55900408 |
| 166 | Pulmonary infiltrates (HP:0002113) | 1.55333459 |
| 167 | Elfin facies (HP:0004428) | 1.54600891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 3.78853854 |
| 2 | MAP3K9 | 3.21449144 |
| 3 | TNK2 | 2.98688416 |
| 4 | MAP2K3 | 2.98045397 |
| 5 | SIK2 | 2.58921909 |
| 6 | PAK6 | 2.31162835 |
| 7 | KSR2 | 2.15815020 |
| 8 | MAP3K11 | 2.09121094 |
| 9 | NTRK3 | 1.83368767 |
| 10 | FES | 1.81973789 |
| 11 | ZAP70 | 1.81676329 |
| 12 | NTRK2 | 1.77181786 |
| 13 | MINK1 | 1.76358429 |
| 14 | DAPK2 | 1.75922091 |
| 15 | CAMKK1 | 1.73569871 |
| 16 | KSR1 | 1.67732577 |
| 17 | CAMK1G | 1.60697246 |
| 18 | TRIB3 | 1.59252067 |
| 19 | BTK | 1.55492340 |
| 20 | ALK | 1.53919199 |
| 21 | GRK1 | 1.52099572 |
| 22 | MAP3K13 | 1.47696890 |
| 23 | RIPK4 | 1.47026974 |
| 24 | PHKG1 | 1.45679675 |
| 25 | PHKG2 | 1.45679675 |
| 26 | MAP4K1 | 1.45318817 |
| 27 | MAP3K14 | 1.45193621 |
| 28 | TBK1 | 1.44822124 |
| 29 | EPHB1 | 1.42332910 |
| 30 | PRKCH | 1.39390723 |
| 31 | PRKD3 | 1.33061898 |
| 32 | SIK3 | 1.32709621 |
| 33 | TAOK1 | 1.29698000 |
| 34 | JAK1 | 1.28805139 |
| 35 | MAP3K3 | 1.24711589 |
| 36 | MAP3K4 | 1.23854138 |
| 37 | RIPK1 | 1.23426203 |
| 38 | CAMK1D | 1.22272513 |
| 39 | NTRK1 | 1.22186310 |
| 40 | MAP3K7 | 1.19621380 |
| 41 | KIT | 1.18810808 |
| 42 | ERN1 | 1.18102250 |
| 43 | EPHB2 | 1.16880115 |
| 44 | MAP3K10 | 1.16480402 |
| 45 | PRKD2 | 1.12827089 |
| 46 | PKN2 | 1.12328127 |
| 47 | RET | 1.11090822 |
| 48 | JAK3 | 1.07923444 |
| 49 | LYN | 1.07878672 |
| 50 | FGFR3 | 1.07087194 |
| 51 | IRAK4 | 1.06821364 |
| 52 | CDK5 | 1.06429896 |
| 53 | CDK19 | 1.03690767 |
| 54 | MAPK12 | 1.00087171 |
| 55 | STK11 | 0.98416119 |
| 56 | TAOK3 | 0.96922216 |
| 57 | HCK | 0.93893361 |
| 58 | EPHA4 | 0.92827612 |
| 59 | TAOK2 | 0.92359809 |
| 60 | LCK | 0.91231184 |
| 61 | TYK2 | 0.90454503 |
| 62 | STK38 | 0.89317701 |
| 63 | BMX | 0.87739884 |
| 64 | BLK | 0.87250788 |
| 65 | RPS6KA2 | 0.85230260 |
| 66 | MAP2K4 | 0.83989881 |
| 67 | SGK2 | 0.82708409 |
| 68 | PRPF4B | 0.81831565 |
| 69 | PRKCZ | 0.81752981 |
| 70 | MARK2 | 0.81045082 |
| 71 | MARK3 | 0.80095984 |
| 72 | YES1 | 0.80055519 |
| 73 | IRAK1 | 0.79853842 |
| 74 | PAK3 | 0.79729250 |
| 75 | PKN1 | 0.79319554 |
| 76 | PTK2B | 0.79103855 |
| 77 | ITK | 0.78501973 |
| 78 | FYN | 0.76823781 |
| 79 | UHMK1 | 0.75516102 |
| 80 | BMPR2 | 0.74438800 |
| 81 | SYK | 0.74026623 |
| 82 | TEC | 0.73221679 |
| 83 | IKBKE | 0.73215875 |
| 84 | MAPK13 | 0.71462796 |
| 85 | SGK3 | 0.71105383 |
| 86 | CLK1 | 0.70270377 |
| 87 | MAP3K1 | 0.69901458 |
| 88 | PDK1 | 0.69022110 |
| 89 | SGK223 | 0.69018942 |
| 90 | SGK494 | 0.69018942 |
| 91 | JAK2 | 0.67216593 |
| 92 | CSK | 0.65178540 |
| 93 | HIPK2 | 0.64650193 |
| 94 | LATS2 | 0.63206361 |
| 95 | FGR | 0.62702898 |
| 96 | SIK1 | 0.61602345 |
| 97 | DAPK1 | 0.60952621 |
| 98 | CAMKK2 | 0.60256482 |
| 99 | WNK1 | 0.58611728 |
| 100 | PTK6 | 0.57135941 |
| 101 | CHUK | 0.56873835 |
| 102 | LRRK2 | 0.56739205 |
| 103 | SGK1 | 0.56728340 |
| 104 | FGFR4 | 0.56318259 |
| 105 | MAP2K7 | 0.55979582 |
| 106 | CAMK1 | 0.55727514 |
| 107 | MAPK7 | 0.54960380 |
| 108 | PDPK1 | 0.54616025 |
| 109 | IRAK2 | 0.54205125 |
| 110 | EPHA3 | 0.54007924 |
| 111 | TXK | 0.53621949 |
| 112 | CSF1R | 0.53400381 |
| 113 | MAP2K6 | 0.53177927 |
| 114 | EEF2K | 0.52775278 |
| 115 | LMTK2 | 0.52133417 |
| 116 | GRK6 | 0.51026900 |
| 117 | CAMK4 | 0.50714138 |
| 118 | DYRK1B | 0.50132323 |
| 119 | TTN | 0.49885097 |
| 120 | DMPK | 0.49863915 |
| 121 | MAP3K5 | 0.49657071 |
| 122 | IKBKB | 0.49160904 |
| 123 | TYRO3 | 0.48731479 |
| 124 | PRKCQ | 0.47566484 |
| 125 | ICK | 0.47460220 |
| 126 | ERBB2 | 0.47100335 |
| 127 | RAF1 | 0.46576676 |
| 128 | ERBB3 | 0.46225240 |
| 129 | PRKAA1 | 0.45498820 |
| 130 | DYRK1A | 0.45089172 |
| 131 | MAP3K12 | 0.43360655 |
| 132 | CDK18 | 0.42952053 |
| 133 | MATK | 0.42895669 |
| 134 | MAP3K6 | 0.42854812 |
| 135 | CDK15 | 0.41912889 |
| 136 | MAP3K2 | 0.41262791 |
| 137 | GRK5 | 0.40592973 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 5.11221428 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.91089037 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 1.88611928 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 1.54982952 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 1.47039464 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 1.45581302 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 1.39753566 |
| 8 | Asthma_Homo sapiens_hsa05310 | 1.39466903 |
| 9 | Measles_Homo sapiens_hsa05162 | 1.38373015 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.35404583 |
| 11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.33866657 |
| 12 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.33146633 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.32563775 |
| 14 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.27437054 |
| 15 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.26768173 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.25075267 |
| 17 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.24237392 |
| 18 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.21767375 |
| 19 | Long-term potentiation_Homo sapiens_hsa04720 | 1.21131553 |
| 20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.21127550 |
| 21 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.19715837 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.19202021 |
| 23 | Nicotine addiction_Homo sapiens_hsa05033 | 1.17845414 |
| 24 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.16772702 |
| 25 | Salivary secretion_Homo sapiens_hsa04970 | 1.16611334 |
| 26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.15480192 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.15142117 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.14740630 |
| 29 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.13458434 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.13376772 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.12967672 |
| 32 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.11369726 |
| 33 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.10334105 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.10313979 |
| 35 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.09721559 |
| 36 | Glioma_Homo sapiens_hsa05214 | 1.07932109 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.07539356 |
| 38 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.06470612 |
| 39 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.04488984 |
| 40 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.03625067 |
| 41 | Legionellosis_Homo sapiens_hsa05134 | 1.03057028 |
| 42 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.02759882 |
| 43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.02229666 |
| 44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.01681269 |
| 45 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.00621843 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.99324577 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.99029934 |
| 48 | * Axon guidance_Homo sapiens_hsa04360 | 0.98800375 |
| 49 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.97076308 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.96592475 |
| 51 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.95805150 |
| 52 | Tuberculosis_Homo sapiens_hsa05152 | 0.95047517 |
| 53 | Insulin secretion_Homo sapiens_hsa04911 | 0.93998842 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.93640072 |
| 55 | Renin secretion_Homo sapiens_hsa04924 | 0.93182736 |
| 56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.92359114 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 0.91478301 |
| 58 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90686911 |
| 59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89878616 |
| 60 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88552676 |
| 61 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.88289897 |
| 62 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.86609007 |
| 63 | Hepatitis B_Homo sapiens_hsa05161 | 0.86569032 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 0.85046270 |
| 65 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.83941953 |
| 66 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.83473415 |
| 67 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.82385792 |
| 68 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.82311921 |
| 69 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.82044879 |
| 70 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.81760369 |
| 71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81696013 |
| 72 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.81392499 |
| 73 | Endometrial cancer_Homo sapiens_hsa05213 | 0.80361850 |
| 74 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.80259920 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.79812451 |
| 76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.79798710 |
| 77 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.79584258 |
| 78 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.79237379 |
| 79 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.78173057 |
| 80 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.78071088 |
| 81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77975693 |
| 82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.77084611 |
| 83 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.76563048 |
| 84 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.76461559 |
| 85 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.75618545 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75367381 |
| 87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.74418831 |
| 88 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.74347731 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.73963077 |
| 90 | Allograft rejection_Homo sapiens_hsa05330 | 0.73027640 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.72938045 |
| 92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.72397711 |
| 93 | Viral myocarditis_Homo sapiens_hsa05416 | 0.71102491 |
| 94 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.69604647 |
| 95 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.68052027 |
| 96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67482156 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.67008043 |
| 98 | Endocytosis_Homo sapiens_hsa04144 | 0.66956394 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66439594 |
| 100 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.66309264 |
| 101 | Salmonella infection_Homo sapiens_hsa05132 | 0.66064684 |
| 102 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.66046075 |
| 103 | Shigellosis_Homo sapiens_hsa05131 | 0.65411391 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65379239 |
| 105 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64924617 |
| 106 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.64707717 |
| 107 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64662937 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.64598446 |
| 109 | Platelet activation_Homo sapiens_hsa04611 | 0.64374743 |
| 110 | Gap junction_Homo sapiens_hsa04540 | 0.64230267 |
| 111 | Cocaine addiction_Homo sapiens_hsa05030 | 0.63761031 |
| 112 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.62683066 |
| 113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62012971 |
| 114 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61775535 |
| 115 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.61557364 |
| 116 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.61045035 |
| 117 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60820317 |
| 118 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.60451416 |
| 119 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59955123 |
| 120 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.59569347 |
| 121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.59001328 |
| 122 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58618635 |
| 123 | Malaria_Homo sapiens_hsa05144 | 0.57921953 |
| 124 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57660088 |
| 125 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56171496 |

